ResearcherMedical College of WisconsinNo recent work listed
Alexander Craig Mackinnon
Matched on ORCID iD 0000-0002-2036-8529; OpenAlex author ID A5060424549. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper
Papers 5
- Increased SPARC expression is associated with neoadjuvant therapy in resectable pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.plabm.2020.e00171↗
- A Serum-Induced Transcriptome and Serum Cytokine Signature Obtained at Diagnosis Correlates with the Development of Early Pancreatic Ductal Adenocarcinoma Meta… Co-author DOI 10.1158/1055-9965.epi-18-0813↗
- A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/sla.0000000000002957↗
- Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/labinvest.2016.146↗
- CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis. Co-author DOI 10.1371/journal.pone.0090400↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Susan Tsai · 4 shared papers, 2014–2019 · strength 0.27
- Paper A Serum-Induced Transcriptome and Serum Cytokine Signature Obtained at Diagnosis Correlates with the Development of Ear… DOI 10.1158/1055-9965.epi-18-0813↗
- Paper A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal Adenocarcinoma. DOI 10.1097/sla.0000000000002957↗
- Paper Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma. DOI 10.1038/labinvest.2016.146↗
- Michael B. Dwinell · 3 shared papers, 2014–2019 · strength 0.20
- Paper A Serum-Induced Transcriptome and Serum Cytokine Signature Obtained at Diagnosis Correlates with the Development of Ear… DOI 10.1158/1055-9965.epi-18-0813↗
- Paper Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma. DOI 10.1038/labinvest.2016.146↗
- Paper CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis. DOI 10.1371/journal.pone.0090400↗
- Douglas B. Evans · 3 shared papers, 2014–2018 · strength 0.19
- Paper A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal Adenocarcinoma. DOI 10.1097/sla.0000000000002957↗
- Paper Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma. DOI 10.1038/labinvest.2016.146↗
- Paper CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis. DOI 10.1371/journal.pone.0090400↗
- Daniel J. Rowan · 1 shared paper, 2020 · strength 0.13
- Christopher Hartley · 1 shared paper, 2020 · strength 0.13
- Ishan Roy · 2 shared papers, 2014–2017 · strength 0.11
- Noah P. Zimmerman · 2 shared papers, 2014–2017 · strength 0.11
- Jill A. Gershan · 1 shared paper, 2019 · strength 0.08
- Mohammed Aldakkak · 1 shared paper, 2019 · strength 0.08
- Jian Zhang · 1 shared paper, 2019 · strength 0.08
- Bradley A. Erickson · 1 shared paper, 2018 · strength 0.07
- William Adrian Hall · 1 shared paper, 2018 · strength 0.07
- Ben George · 1 shared paper, 2018 · strength 0.07
- Parag P. Tolat · 1 shared paper, 2018 · strength 0.07
- Syed Arif Ahmad · 1 shared paper, 2018 · strength 0.07
- Kulwinder S. Dua · 1 shared paper, 2018 · strength 0.07
- Kathleen K. Christians · 1 shared paper, 2018 · strength 0.07
- Rosa F. Hwang · 1 shared paper, 2017 · strength 0.06
- Emily P. Vonderhaar · 1 shared paper, 2017 · strength 0.06
- Janusz Franco‐Barraza · 1 shared paper, 2017 · strength 0.06
- Edna Cukierman · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.